论文部分内容阅读
患儿,男,2010年4月15日出生,第一胎,足月顺产,发育正常,身体健康,无过敏史,父母既往体健,无家族病史。出生当日在医院按照免疫程序接种重组乙型肝炎(乙肝)疫苗(酿酒酵母)(Hepatitis B Vaccine Made by Recombinant Deoxyribonucleic Acid Techniques inSaccharomyces CerevisiaeYeast,HepB-SCY)1剂0.5毫升(ml),北京天坛生物制品有限公司生产,批号2009110203,有效期至2012年11月17日。接种部位为右上臂三角肌中部肌内注射,含乙肝病毒表面抗原5微克(μg);同时接种卡介苗1剂0.1ml,接种部位为左上臂三角肌中部附
Child, male, born April 15, 2010, first child, term full-term, normal development, good health, no history of allergy, past physical past, no history of family history. Hepatitis B Vaccine Made by Recombinant Deoxyribonucleic Acid Techniques in Saccharomyces cerevisiae Yeast (HepB-SCY) 0.5 ml (ml), Beijing Tiantan Biological Products Co., Ltd. Company production, lot number 2009110203, valid until November 17, 2012. Inoculation site is the right upper quadrant deltoid muscle injection, containing hepatitis B virus surface antigen 5 micrograms (μg); at the same time vaccination BCG 1 0.1ml, the vaccination site for the upper left arm deltoid with